These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6194135)

  • 1. Labeled bleomycin as a tumor localizing agent III. Selectivity of tumor tissue uptake of the different forms of [57Co] bleomycin A2 and B2.
    Vos CM; Westera G
    Int J Nucl Med Biol; 1982; 9(4):237-43. PubMed ID: 6194135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labelled bleomycin as a tumour-localizing agent. II. The effect of dose loading of the different forms of 57Cobalt-bleomycin A2, B2, and pepleomycin on the tissue distribution and tumour uptake in tumour-bearing rats.
    Vos CM; Westera G
    Eur J Nucl Med; 1982; 7(2):92-4. PubMed ID: 6177534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dose loading and of double labelling with 57Co and 125I on the tissue distribution in animals.
    Vos CM; Westera G; van der Jagt PJ; van Zanten B
    Eur J Nucl Med; 1979 Oct; 4(5):393-6. PubMed ID: 93048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Work in progress: the effect of heat on bleomycin cytotoxicity in vitro and on the accumulation of 57Co-bleomycin in heat-treated rat tumors.
    Lin PS; Cariani PA; Jones M; Kahn PC
    Radiology; 1983 Jan; 146(1):213-7. PubMed ID: 6184743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular distribution of 57Co-bleomycin.
    Konings AW; Rasker JJ; Posthuma GA
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):497-512. PubMed ID: 76527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical and biologic properties of isolated radiolabeled bleomycin preparations.
    Eckelman WC; Rzeszotarski WJ; Siegel BA; Kubota H; Chelliah M; Stevenson J; Rebra RC
    J Nucl Med; 1975 Nov; 16(11):1033-7. PubMed ID: 52699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and biological properties of bleomycin labelled with 57Co.
    Raban P; Brousil J; Svihovcová P
    Eur J Nucl Med; 1979 Jun; 4(3):191-7. PubMed ID: 91512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative studies on the uptake and organ distribution of 57Co-bleomycin and 57Co-bleomycin-A2 in mice with squamous cell tumors of the skin and vagina].
    Pertynski T; Ketkar MB; Mariss P; Reznik G; Talas A; Dieffenbach G
    Nuklearmedizin; 1979; 18(6):300-3. PubMed ID: 94162
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of uptake of 67Ga-citrate and 57Co-bleomycin in tumor using a semiconductor detector.
    Higashi T; Kanno M; Tomura K
    J Nucl Med; 1974 Dec; 15(12):1167-70. PubMed ID: 4139249
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA interaction with 57Co-bleomycin.
    Kakinuma J; Orii H
    Nuklearmedizin; 1982 Dec; 21(6):232-5. PubMed ID: 6188112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of 57Co-bleomycetin accumulation in the primary tumor and in its metastases to the lungs in mice with Lewis carcinoma].
    Vatin OE; Petriev VM; Prusova RM
    Antibiotiki; 1983 Sep; 28(9):686-9. PubMed ID: 6195962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of chemotherapy on the distribution of 57Co-bleomycin in chemically induced squamous cell carcinoma of mouse skin.
    Pertynski T; Reznik G; Mariss P; Ketkar MB; Haindl H; Dieffenbach G
    Eur J Nucl Med; 1979 Feb; 4(1):55-9. PubMed ID: 91511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular localization of 57Co-bleomycin in normal and tumor tissues.
    Konings AW; Rasker JJ
    Strahlentherapie; 1978 Jan; 154(1):63-70. PubMed ID: 75596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of 57Co-bleomycin A5 in the body of animals with various inoculated tumors].
    Petriev VM; Chacirov DG; Prusova RM
    Radiobiol Radiother (Berl); 1983; 24(6):769-77. PubMed ID: 6199810
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical properties and tumor affinity of separated isomers of cobalt-bleomycin.
    Kakinuma J; Kagiyama R; Orii H
    Eur J Nucl Med; 1980 Apr; 5(2):159-63. PubMed ID: 6155270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental basis for the diagnostic use of bleomycetin-57Co].
    Khachirov DG; Petriev VM; Matveenko EG; Prusova RM
    Med Radiol (Mosk); 1980 Jun; 25(6):22-7. PubMed ID: 6156371
    [No Abstract]   [Full Text] [Related]  

  • 17. [57Co-bleomycetin pharmacokinetics in the body of mice with LIO-1 lymphosarcoma].
    Petriev VM; Vatin AE; Prusova RM; Filatov PP; Khachirov DG
    Antibiotiki; 1982 Aug; 27(8):623-6. PubMed ID: 6181732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Positive tumor scintigraphy. I. Pharmacokinetics of 111In and 57Co bleomycin].
    Blottner A; Deckart H; Weiland J
    Radiobiol Radiother (Berl); 1978 Jun; 19(3):365-77. PubMed ID: 82976
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of radiolabeled bleomycins and gallium citrate in tumor-bearing mice.
    Krohn KA; Meyers JM; DeNardo GL; DeNardo SJ
    J Nucl Med; 1977 Mar; 18(3):276-81. PubMed ID: 65460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of radio-labelled bleomycin for tumor detection.
    Rasker JJ; Beekhuis H; van de Poll MA; Versluis A; Jurjens H; Woldring MG
    Nuklearmedizin; 1978 Dec; 17(6):238-48. PubMed ID: 84374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.